Are patients with non-ST elevation myocardial infarction undertreated?

BMC Cardiovascular Disorders

Volumn 7, Issue , 2007, Pages

  Rasoul, Saman ^a   Ottervanger, Jan ^a   Dambrink, Jan Henk E ^a   de Boer, Menko Jan ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Zijlstra, Felix ^b   Suryapranata, Harry ^a   van't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; CARDIOVASCULAR AGENT;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; AGE DISTRIBUTION; CARDIOLOGY; COMORBIDITY; COMPARATIVE STUDY; HEALTH CARE QUALITY; HEART CATHETERIZATION; HEART MUSCLE REPERFUSION; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UTILIZATION REVIEW;

AGE DISTRIBUTION; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOLOGY; CARDIOVASCULAR AGENTS; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NETHERLANDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; QUALITY OF HEALTH CARE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33947654918     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-7-8     Document Type: Article

References (37)

1. Van de Werf F Ardissino D Betriu A Cokkinos DV Falk E Fox KA Julian D Lengyel M Neumann FJ Ruzyllo W Thygesen C Underwood SR Vahanian A Verheugt FW Wijns W Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patientspresenting with ST-segment elevation Eur Heart J 2003 24 28-66 10.1016/S0195-668X(02)00618-8 12559937
2. Boersma E Maas AC Deckers JW Simoons ML Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour Lancet 1996 348 771-775 10.1016/S0140-6736(96)02514-7 8813982
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and morbidity resultsfrom all randomised trials of more than 1000 patients Lancet 1994 343 311-322 7905143
4. Keeley EC Boura JA Grines CL Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials Lancet 2003 361 13-20 10.1016/ S0140-6736(03)12113-7 12517460
5. Braunwald E Antman EM Beasley JW Califf RM Cheitlin MD Hochman JS Jones RH Kereiakes D Kupersmith J Levin TN Pepine CJ Schaeffer JW Smith EE 3rd Steward DE Theroux P Gibbons RJ Alpert JS Faxon DP Fuster V Gregoratos G Hiratzka LF Jacobs AK Smith SC Jr American College of Cardiology; American Heart Association ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-A002: Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) Circulation 2002 106 1893-1900 10.1161/01.CIR.0000037106.76139.53 12356647
6. Braunwald E Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation 2003 108 28-37 10.1161/01.CIR.0000086952.14979.32
7. Terkelsen CJ Lassen JF Norgaard BL Gerdes JC Jensen T Gotzsche LB Nielsen TT Andersen HR Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: Observations from an unselected cohort Eur Heart J 2005 26 18-26 10.1093/eurheartj/ehi002 15615795
8. Hasdai D Behar S Wallentin L Gitt AK Boersma E Fioretti PM Simoons ML Battler A A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 2002 23 1190-1201 10.1053/ euhj.2002.3193 12127921
9. Goldberg RJ Currie K White K Brieger D Steg PG Goodman SG Dabbous O Fox KA Gore JM Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]) Am J Cardiol 2004 93 288-293 10.1016/ j.amjcard.2003.10.006 14759376
10. Andersen HR Nielsen TT Rasmussen Thuesen L Kelbaek H Thayssen P Abildgaard U Pedersen F Madsen JK Grande P Villadsen AB Krusell LR Haghfelt T Lomholt P Husted SE Vigholt E Kjaergard HK Mortensen LS DANAMI-2 Investigators A Comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 2003 349 733-742 10.1056/NEJMoa025142 12930925
11. The GUSTO V Investigators Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial Lancet 2001 357 1905-1914 10.1016/S0140-6736(00)05059-5 11425410
12. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators Single-bolus tenecteplase compared with front-loadedalteplase in acute myocardial infarction: The ASSENT-2 double blind randomised trial Lancet 1999 354 716-722 10.1016/ S0140-6736(99)07403-6 10475182
13. Sinnaeve P Alexander J Belmans A Bogaerts K Langer A Diaz R Ardissino D Vahanian A Pehrsson K Armstrong P Van de Werf F ASSENT-2 Investigators One-year follow-up of the ASSENT-2 trial: A double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acutemyocardial infarction Am Heart J 2003 146 27-32 10.1016/S0002-8703(03)00117-0 12851604
14. Lincoff AM Califf RM Van de WF Willerson JT White HD Armstrong PW Guetta V Gibler WB Hochman JS Bode C Vahanian A Steg PG Ardissino D Savonitto S Bar F Sadowski Z Betriu A Booth JE Wolski K Waller M Topol EJ Global Use of Strategies To Open Coronary Arteries Investigators (GUSTO) Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial JAMA 2002 288 2130-2135 10.1001/jama.288.17.2130 12413372
15. Rothwell PM External validity of randomised controlled trials: To whom do the results of this trial apply?" Lancet 2005 365 82-93 10.1016/ S0140-6736(04)17670-8 15639683
16. Black N Why we need observational studies to evaluate the effectiveness of health care BMJ 1996 312 1215-1218 8634569
17. McKee M Britton A Black N McPherson K Sanderson C Bain C Methods in health service research. Interpreting the evidence: Choosing between randomised and non-randomised studies BMJ 1999 319 312-315 1126943 10426754
18. Bach RG Cannon CP Weintraub WS DiBattiste PM Demopoulos LA Anderson HV DeLucca PT Mahoney EM Murphy SA Braunwald E Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: Observations from the OPUS-TIMI 16 trial Ann Intern Med 2004 141 186-195 15289215
19. de Boer MJ Ottervanger JP van 't Hof AWJ Hoorntje JCA Suryapranata H Zijlstra F Zwolle Myocardial Infarction Study Group Reperfusion therapy in elderly patients with acute myocardial infarction: A randomized comparison of primary angioplasty and thrombolytic therapy J Am Coll Cardiol 2002 39 1723-1728 10.1016/S0735-1097(02)01878-8 12039482
20. Abbas AE Boura JA Brewington SD Dixon SR O'Neill WW Grines CL Acute angiographic analysis of non ST segment elevation acute myocardial infarction Am J Cardiol 2004 94 907-909 10.1016/j.amjcard.2004.06.026 15464674
21. Almeda FQ Hendel RC Nathan S Meyer PM Calvin JE Klein LW Improved in-hospital outcomes in acute coronary syndromes(unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores J Invasive Cardiol 2003 15 502-506 12947210
22. Niemela K Vikman S Early invasive therapy of non ST-elevation acute coronary syndromes - combined with upstream antiplatelet therapy: Yes - but how early? Eur Heart J 2003 24 1383-1384 10.1016/ S0195-668X(03)00281-1 12909065
23. Newby LK Alpert JS Ohman EM Thygesen K Califf RM Changing the diagnosis of acute myocardial infarction: Implicationsfor practice and clinical investigations Am Heart J 2002 144 957-980 10.1067/mhj.2002.129778 12486420
24. Alpert JS Thygesen K Antman E Bassand JP Myocardial infarction redefined - a consensus document of The Joint European Society ofCardiology/ American College of Cardiology Committee for the redefinition ofmyocardial infarction J Am Coll Cardiol 2000 36 959-969 10.1016/ S0735-1097(00)00804-4 10987628
25. Roe MT Parsons LS Pollack CV Jr Canto JG Barron HV Every NR Rogers WJ Peterson ED National Registry of Myocardial Infarction Investigators Quality of care by classification of myocardial infarction: Treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction Arch Intern Med 2005 165 1630-1636 10.1001/ archinte.165.14.1630 16043682
26. Escabi-Mendoza J Rosales-Alvarez C Risk stratification in the patient with non ST segment elevation acute coronary syndrome P R Health Sci J 2005 24 323-336 16570530
27. Kleiman NS Lakkis N Cannon CP Murphy SA DiBattiste PM Demopoulos LA Weintraub WS Braunwald E TACTICS-TIMI 18 Investigators Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol 2002 40 1044-1050 10.1016/S0735-1097(02)02119-8 12354426
28. Antman EM Cohen M Bernink PJ McCabe CH Horacek T Papuchis G Mautner B Corbalan R Radley D Braunwald E The TIMI risk score for unstable angina/ non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 2000 284 835-842 10.1001/jama.284.7.835 10938172
29. Maseri A Rebuzzi AG Cianflone D Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice Circulation 1997 96 4141-4142 9416880
30. Mega JL Morrow DA Sabatine MS Zhao XQ Snapinn SM DiBattiste PM Gibson CM Antman EM Braunwald E Theroux P Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Am Heart J 2005 149 846-850 10.1016/ j.ahj.2004.08.042 15894966
31. Cannon CP Weintraub WS Demopoulos LA Vicari R Frey MJ Lakkis N Neumann FJ Robertson DH DeLucca PT DiBattiste PM Gibson CM Braunwald E TACTICS-TIMI 18 Investigators Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 2001 344 1879-1887 10.1056/NEJM200106213442501 11419424
32. Morrow DA Cannon CP Rifai N Frey MJ Vicari R Lakkis N Robertson DH Hille DA DeLucca PT DiBattiste PM Demopoulos LA Weintraub WS Braunwald E TACTICS-TIMI 18 Investigators Ability of minor elevations of troponins I and T to predict benefit from a early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial JAMA 2001 286 2405-2412 10.1001/jama.286.19.2405 11712935
33. Roe MT Ohman EM Pollack CV Jr Peterson ED Brindis RG Harrington RA Christenson RH Smith SC Jr Califf RM Gibler WB Changing the model of care for patients with acute coronary syndromes Am Heart J 2003 146 605-612 10.1016/S0002-8703(03)00388-0 14564312
34. Rasoul S Ottervanger JP de Boer MJ Miedema K Hoorntje JCA Gosselink ATM Zijlstra F Suryapranata H Dambrink JHE van 't Hof AWJ A comparison of dual versus triple antiplatelet therapyin patients with non ST segment elevation acute coronary syndromes. Results of the ELISA-2 trial Eur Heart J 2006 27 1401-1407 10.1093/eurheartj/ehl004 16682384
35. Kastrati A Mehilli J Neumann FJ Dotzer F ten Berg J Bollwein H Graf I Ibrahim M Pache J Seyfarth M Schuhlen H Dirschinger J Berger PB Schomig A Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial JAMA 2006 295 1531-1538 10.1001/jama.295.13.joc60034 16533938
36. Mehta RH Montoye CK Gallogly M Baker P Blount A Faul J Roychoudhury C Borzak S Fox S Franklin M Freundl M Kline-Rogers E LaLonde T Orza M Parrish R Satwicz M Smith MJ Sobotka P Winston S Riba AA Eagle KA GAP Steering Committee of the American College of Cardiology Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative JAMA 2002 287 1269-1276 10.1001/ jama.287.10.1269 11886318
37. Wellens HJ Acute myocardial infarction and left bundle-branch block - can we lift the veil? N Engl J Med 1996 334 528-529 10.1056/ NEJM199602223340809 8559208